Publication: Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method
| dc.contributor.author | Saen-Oon S. | |
| dc.contributor.author | Kuno H. | |
| dc.contributor.author | Hannongbua S. | |
| dc.date.accessioned | 2021-04-05T04:32:29Z | |
| dc.date.available | 2021-04-05T04:32:29Z | |
| dc.date.issued | 2005 | |
| dc.date.issuedBE | 2548 | |
| dc.description.abstract | Two-layered and three-layered ONIOM calculations were performed to compare the binding energies of 8-Cl TIBO inhibitor when bound into the human immunodeficiency virus reverse transcriptase binding pocket and a Y181C variant. Both consisted of 20 residues within a radius of 15 Å. A combination of different methods [HP2/6-31G(d), B3LYP/6-31G(d,p), and PM3] were performed to take advantage of ONIOM's layering strategy analysis. The obtained results clearly indicate that the Y181C mutation reduces the binding affinity and stability of the inhibitor by approximately 8-9 kcal/mol as obtained from different combined MO:MO methods. Analyses regarding the energetic components of the interaction and deformation energies for 8-Cl TIBO inhibitor upon binding were also examined extensively. Additional calculations involving the interaction energies between 8-Cl TIBO with individual residues surrounding the binding pocket were performed at MP2/6-31G(d,p) and B3LYP/6-31G(d,p) levels of theory to gain more insight into the energetic differences of wild-type and Y181C mutant type at the atomistic level. © 2005 Wiley-Liss, Inc. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Proteins: Structure, Function and Genetics. Vol 61, No.4 (2005), p.859-869 | |
| dc.identifier.doi | 10.1002/prot.20690 | |
| dc.identifier.issn | 8873585 | |
| dc.identifier.other | 2-s2.0-28644442414 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/6042 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | 4,5,6,7 tetrahydroimidazo 8 chloro 5 methyl (3 methyl 2 butenyl)imidazo | |
| dc.subject.other | RNA directed DNA polymerase | |
| dc.subject.other | RNA directed DNA polymerase inhibitor | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Analytic method | |
| dc.subject.other | Article | |
| dc.subject.other | Binding affinity | |
| dc.subject.other | Calculation | |
| dc.subject.other | Comparative study | |
| dc.subject.other | Complex formation | |
| dc.subject.other | Drug binding site | |
| dc.subject.other | Drug protein binding | |
| dc.subject.other | Energy | |
| dc.subject.other | Human immunodeficiency virus 1 | |
| dc.subject.other | Molecular stability | |
| dc.subject.other | Mutation | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Priority journal | |
| dc.subject.other | Quantum chemistry | |
| dc.subject.other | Wild type | |
| dc.subject.other | Amino Acid Substitution | |
| dc.subject.other | Dimerization | |
| dc.subject.other | HIV-1 | |
| dc.subject.other | Kinetics | |
| dc.subject.other | Models, Molecular | |
| dc.subject.other | Polymorphism, Single Nucleotide | |
| dc.subject.other | Protein Structure, Secondary | |
| dc.subject.other | Protein Subunits | |
| dc.subject.other | Quantum Theory | |
| dc.subject.other | Recombinant Proteins | |
| dc.subject.other | Reverse Transcriptase Inhibitors | |
| dc.subject.other | RNA-Directed DNA Polymerase | |
| dc.subject.other | Thermodynamics | |
| dc.subject.other | Human immunodeficiency virus | |
| dc.subject.other | Human immunodeficiency virus 1 | |
| dc.title | Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-28644442414&doi=10.1002%2fprot.20690&partnerID=40&md5=bdfa20e816813bf3ae48971687134dd4 |
